ADENOVIRUS INFECTION IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS

被引:147
|
作者
MICHAELS, MG
GREEN, M
WALD, ER
STARZL, TE
机构
[1] UNIV PITTSBURGH,SCH MED,DEPT PEDIAT,PITTSBURGH,PA 15261
[2] UNIV PITTSBURGH,SCH MED,DEPT SURG,PITTSBURGH,PA 15261
来源
JOURNAL OF INFECTIOUS DISEASES | 1992年 / 165卷 / 01期
关键词
D O I
10.1093/infdis/165.1.170
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A retrospective review of adenoviral infection in pediatric liver transplant recipients was done at Children's Hospital of Pittsburgh to define its epidemiology and clinical importance. Medical records of patients with adenovirus were reviewed and data collected regarding clinical course, microbiologic studies, biopsy results, immunosuppression, concurrent infections, and outcome. Of 484 liver transplant recipients, 49 had 53 episodes of adenoviral infection. The most common sites of adenoviral infection were the liver, lung, and gastrointestinal tract. Serotypes 1, 2, and 5 were recovered most often; type 5 was commonly associated with hepatitis. Invasive adenoviral infection occurred in 20 children, leading to death in 9. Median time from transplantation until isolation of adenovirus was 25.5 days. This timing suggests either reactivation or donor-associated transmission. Prospective studies using molecular epidemiologic techniques will be helpful in evaluating transmission patterns of adenovirus in this population.
引用
收藏
页码:170 / 174
页数:5
相关论文
共 50 条
  • [21] CONGENITAL CYTOMEGALOVIRUS-INFECTION IN OFFSPRING OF LIVER-TRANSPLANT RECIPIENTS
    LAIFER, SA
    EHRLICH, GD
    HUFF, DS
    BALSAN, MJ
    SCANTLEBURY, VP
    CLINICAL INFECTIOUS DISEASES, 1995, 20 (01) : 52 - 55
  • [22] OKT3 AS PROPHYLAXIS IMMUNOSUPPRESSION IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS
    SOMMERAUER, JF
    ATKISON, P
    HOWARD, J
    GRANT, D
    WALL, W
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (01) : 154 - 156
  • [23] OKT3 INDUCTION THERAPY IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS
    RYCKMAN, FC
    SCHROEDER, TJ
    PEDERSEN, SH
    FISHER, RA
    TCHERVENKOV, JI
    ZIEGLER, M
    FARRELL, M
    HEUBI, J
    BALISTRERI, WF
    HEPATOLOGY, 1990, 12 (04) : 863 - 863
  • [24] OKT3 AND VIRAL DISEASE IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS
    BOWMAN, JS
    GREEN, M
    SCANTLEBURY, VP
    TODO, S
    TZAKIS, A
    IWATSUKI, S
    DOUGLAS, L
    STARZL, TE
    CLINICAL TRANSPLANTATION, 1991, 5 (04) : 294 - 300
  • [25] Candida infection in pediatric liver transplant recipients
    Gladdy, RA
    Richardson, SE
    Davies, HD
    Superina, RA
    LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (01): : 16 - 24
  • [26] RESPIRATORY SYNCYTIAL VIRUS-INFECTIONS IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS
    POHL, C
    GREEN, M
    WALD, ER
    LEDESMAMEDINA, J
    JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01): : 166 - 169
  • [27] Enteric adenovirus infection in pediatric small bowel transplant recipients
    Parizhskaya, M
    Walpusk, J
    Mazariegos, G
    Jaffe, R
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2001, 4 (02) : 122 - 128
  • [28] Prospective Assessment of Adenovirus Infection in Pediatric Kidney Transplant Recipients
    Engen, Rachel M.
    Huang, Meei-Li
    Park, Giulia E.
    Smith, Jodi M.
    Limaye, Ajit P.
    TRANSPLANTATION, 2018, 102 (07) : 1165 - 1171
  • [29] Basiliximab in paediatric liver-transplant recipients
    Vester, U
    Kranz, B
    Treichel, U
    Hoyer, PF
    LANCET, 2001, 357 (9253): : 388 - 389
  • [30] EXCLUSION CRITERIA FOR LIVER-TRANSPLANT RECIPIENTS
    SHAW, BW
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (03) : 3484 - 3486